Showing results (11-20 of 91) with videos related to
Sort By:
Pageof 10
Cardiovascular Therapeutics|July 31, 2016
Adherence to therapies for secondary prevention of cardiovascular disease: a focus on aspirinKathleen A Packard, Daniel E HillemanPharmacotherapy|November 5, 2003
Pharmacologic treatment of chronic obstructive pulmonary disease: past, present, and futureMichele A Faulkner, Daniel E HillemanPharmacotherapy|January 17, 2002
Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trialsDaniel E Hilleman, Sarah A SpinlerJournal of Vascular and Interventional Radiology : JVIR|February 26, 2008
Clinical and economic evaluation of the Trellis-8 infusion catheter for deep vein thrombosisDaniel E Hilleman, Mahmood K RazaviManaged Care (Langhorne, Pa.)|August 3, 2010
Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapyMark A Malesker, Daniel E HillemanExpert Opinion on Pharmacotherapy|June 30, 2006
Pharmacoeconomic considerations with statin therapyKatie M Speidel, Daniel E HillemanExpert Opinion on Pharmacotherapy|February 28, 2002
The economic impact of chronic obstructive pulmonary diseaseMichele A Faulkner, Daniel E HillemanClinical Medicine Insights. Cardiology|February 12, 2014
Potential benefits of icosapent ethyl on the lipid profile: case studiesDaniel E Hilleman, Mark A MaleskerPharmacotherapy|September 2, 2004
Angiotensin-converting enzyme inhibitors and stroke risk: benefit beyond blood pressure reduction?Daniel E Hilleman, B Daniel LucasJournal of Critical Care|February 4, 2012
Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically ill patientsMark A Malesker, Daniel E HillemanPageof 10